Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523, a Syk Inhibitor, in Adult Subjects With Immune Thrombocytopenia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06291415
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:19.066808+00:00
Published At
2025-09-16T00:00:00+00:00
Record Updated At
2025-09-16
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Immune Thrombocytopenia", "Blood Platelet Disorder", "Hematologic Diseases", "Purpura, Thrombocytopenic", "Purpura", "Blood Coagulation Disorder", "Thrombotic Microangiopathies", "Hemorrhagic Disorders", "Autoimmune Diseases", "Immune System Diseases", "Hemorrhage", "Pathologic Processes", "Skin Manifestations", "Thrombocytopenia", "Purpura, Thrombocytopenic, Idiopathic", "Primary Immune Thrombocytopenia", "ITP - Immune Thrombocytopenia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-09-16"
protocolSection.identificationModule.nctId
"NCT06291415"
protocolSection.identificationModule.officialTitle
"A Multicenter, Phase 1b Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523, a Syk Inhibitor, in Adult Subjects With Immune Thrombocytopenia"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Immune Thrombocytopenia (protocolSection.conditionsModule.conditions)
  • Blood Platelet Disorder (protocolSection.conditionsModule.conditions)
  • Hematologic Diseases (protocolSection.conditionsModule.conditions)
  • Purpura, Thrombocytopenic (protocolSection.conditionsModule.conditions)
  • Purpura (protocolSection.conditionsModule.conditions)
  • Blood Coagulation Disorder (protocolSection.conditionsModule.conditions)
  • Thrombotic Microangiopathies (protocolSection.conditionsModule.conditions)
  • Hemorrhagic Disorders (protocolSection.conditionsModule.conditions)
  • Autoimmune Diseases (protocolSection.conditionsModule.conditions)
  • Immune System Diseases (protocolSection.conditionsModule.conditions)
  • Hemorrhage (protocolSection.conditionsModule.conditions)
  • Pathologic Processes (protocolSection.conditionsModule.conditions)
  • Skin Manifestations (protocolSection.conditionsModule.conditions)
  • Thrombocytopenia (protocolSection.conditionsModule.conditions)
  • Purpura, Thrombocytopenic, Idiopathic (protocolSection.conditionsModule.conditions)
  • Primary Immune Thrombocytopenia (protocolSection.conditionsModule.conditions)
  • ITP - Immune Thrombocytopenia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.